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ABSTRACT
Objectives: The aim of this study was to assess the maternal and neonatal outcome in patients with preterm premature 
rupture of membranes between 22 to 37 weeks of gestation in comparison to preterm birth patients.
Material and methods: Group of PPROM patients consisted of 127 women, the control group counted 141 women who 
delivered prematurely. The control group was formed by matching patient with the same gestational age at delivery 
and neonatal birth weight to every woman from study group. In both groups speculum and ultrasound examinations 
were performed, microbiological swabs were taken. In unclear cases of PPROM tests detecting amniotic proteins, such 
as PAMG-1 or IGFBP-1, were performed. According to gestational age at delivery, neonates were divided into subgroups: 
extremely premature infants (< 27 weeks 6 days), moderate premature infants (from 28 weeks 0 days to 33 weeks 6 days), 
late premature infants (from 34 weeks 0 days to 37 weeks 0 days). 
Results: In the study group, median gestational age of delivery was 34 weeks 1 day and the same in control group — 34 weeks 
and 5 days (p > 0.05). Parameters of inflammatory status were more often reported in the PPROM group than in the preterm 
birth group, even if they weren’t statistically significant (positive culture of cervical swab, increased leukocytosis, CRP above 5).
The rate of neonate survival was similar in both groups (93.7% and 94.1%). Congenital infection was more often diagnosed in 
group of neonates from PPROM pregnancies than in neonates from control group; (36% and 21.2% respectively; p = 0.009).
Conclusions: Our research appears to be consistent with theory of inflammatory etiology of PPROM. Optimal management 
of infection in PPROM patients seems to be the most important in efforts to prolong pregnancy.
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INTRODUCTION
Preterm rupture of membranes (PROM) complicates ap-
proximately 2–5% of pregnancies before term and 8% of term 
gestations [1]. At term it does not significantly influence preg-
nancy outcome. If it happens before 37 weeks, we describe it 
as preterm premature rupture of membranes (PPROM) and it 
increases the risk of preterm labor, intrauterine infection, fetal 
hypoxia and intrauterine death [1, 2]. Pregnancy outcome in 
cases of spontaneous PPROM depends on gestational age. 
Approximately 50% of patients deliver within a week after 
PPROM, latency in the other half depends on gestational age, 
fetal condition and presence of infection [3].
Depending on the gestational age, fetal and maternal 
condition, there is a possibility of conservative manage-
ment, including steroids administration, antibiotics and 
magnesium sulfate or active labor induction after steroids 
administration [4]. Tocolytics are usually not recommended 
because uterine contractions are usually correlated to in-
trauterine infection and prolongation of pregnancy in these 
cases does not decrease the mortality and morbidity of 
women and children [5, 6].
Lack of amniotic fluid in the uterus, especially before 
the 24th week of gestation, disturbs fetal lung development. 
Alveoli do not form without amniotic fluid even after ster-
oids administration. Respiratory distress in children born 
after PPROM, after they had spent some time in uterus 
without amniotic fluid, is often more severe than we expect. 
Neonates have also higher risk of severe inborn infection. 
Both factors — respiratory distress and infection — worsen 
prognosis for the children after PPROM [7, 8].
There are only a few trials trying to compare differ-
ent approaches to ahydramnios caused by PPROM. They 
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concentrate on two topics: sealing the hole in membranes 
(amniopatch, immunologic sealants, membranes) and sup-
plementing amniotic fluid (amnioinfusion). As of now, there 
is no answer to if any type of treatment improves pregnancy 
outcome [9, 10].
Objectives
Authors compared pregnancy outcome in patients who 
delivered before term with and without PPROM.
MATERIAL AND METHODS
The study group consisted of 127 women who were ad-
mitted to the Department of Obstetrics of Medical University 
from October 2009 to 2014 with preterm premature rupture 
of membranes (between 22 and 37 weeks of gestation).The 
control group (141 women) was formed by matching patient 
with the same gestational age at delivery and neonatal 
birth weight to every woman from study group. Accord-
ing to gestational age at delivery, neonates were divided 
into subgroups: extremely premature infants (< 27 weeks 
6 days), moderate premature infants (from 28 weeks 0 days 
to 33 weeks 6 days), late premature infants (from 34 weeks 
6 days to 37 weeks 0 days). 
To confirm PPROM, sterile speculum examinations were 
performed with the visualization of amniotic fluid leaking from 
the cervical canal. In unclear cases tests detecting amniotic 
proteins, such as PAMG-1 (Placental alpha microglobulin-1) 
or IGFBP-1 (Insulin —like growth factor binding protein 1), 
were performed. Ultrasound examinations were performed 
in every patient — fetal well-being, amniotic fluid index 
and signs of placental abruption were determined. The 
exclusion criteria included: multiple pregnancy, intrauterine 
fetal death, fetal congenital malformations, previous cervical 
surgery and uncertain diagnosis of PPROM. 
According to our Department regulation, patients with 
PPROM before 34 weeks 0 days of gestation were managed 
expectantly if no maternal or fetal contraindication were 
present. Induction of labor wasn’t offered to these patients 
unless intrauterine infection was diagnosed. Tocolysis wasn’t 
ordered to pregnant patients with PPROM. A single course 
of corticosteroids was offered to every pregnant woman be-
tween 24 weeks 0 days and 34 weeks 6 days. Prophylactic 
antibiotics were given to patients in the latent phase of 
PPROM from 24 weeks 0 days to 33 weeks 6 days. Every week 
patients were examined vaginally (speculum examination) 
and had cervical swabs taken. If a microbiological swab was 
positive, antibiotics were administered. Similarly, CRP and 
leukocytosis were evaluated every week. Fetal status was 
assessed every seven days by ultrasound examination. In 
case of patients with PPROM after 34 weeks 0 days of ges-
tation, who didn’t have contraindication to labor, delivery 
was induced, mostly with Oxytocin infusion (usually after 
12 hours of expectancy for spontaneous contractions). Nei-
ther tocolysis nor corticosteroids were offered in this group 
of patients. Maternal infusion of magnesium sulfate as fetal 
neuroprotection wasn’t recommended for patients before 
32 weeks 0 days.
Data from medical records were analyzed to compare 
pregnancy complications and outcome in the study group 
and control group. Information regarding gestational age 
at PPROM, laboratory symptoms of infection (CRP > 5, leu-
kocytosis > 15000/dL, positive culture of cervical swab), 
steroids and antibiotics administration, gestational age at 
delivery, mode of delivery, indication for cesarean section, 
birth weight of neonate, respiratory distress syndrome (type 
of assisted ventilation), leukocytosis and CRP in neonate, 
results of microbiological tests in neonates, length of hospi-
tal stay of neonate was collected. Congenital infection was 
diagnosed based on a minimum of two signs of infection in 
clinical examination and/or increased values of inflamma-
tory parameters in neonate. Clinical symptoms of congenital 
infection were defined as breathing disturbances (tachyp-
nea, apnea), tachycardia, bradycardia, significant variability 
of heart rate, emesis, hypotonia, muscle tremors, convul-
sions, instability of body temperature, lethargy, circulation 
disturbances, and metabolic disturbances.
The normality of the layout of continuous variables was 
assessed by means of the Shapiro-Wilk test. Statistical char-
acteristics of continuous variables were presented by means 
of arithmetic means, standard deviations, medians as well as 
minimal and maximal values. For inter-group comparisons 
Student’s t-test for non-linked variables or U Mann-Whitney 
test were applied. In order to compare the layouts of dis-
crete variables, Pearson’s chi-squared test or Fisher’s exact 
test were used. All calculations were carried out by means 
of Statistica10 software (StatSoft, the USA), where value 
p < 0.05 was accepted as a statistically significant.
RESULTS
Average patient age at admission to hospital was 
30.2 ± 5.4 years in the study group and 29.8 ± 4.8 years in 
the control group (p > 0.05). As far as gravidity was con-
cerned, 48% of the patients in study group and 43.3% of 
the patients in control group were nulliparous, while 52% 
and 56.7% had had at least one delivery (p > 0.05). In the 
study group of 127 women median gestational age of de-
livery was 34 weeks 1 day (23 weeks and 5 days to 37 weeks 
0 days) and the same in the control group — 34 weeks and 
5 days, from 22 weeks and 4 days to 37 weeks and 0 days 
(p > 0.05). Median gestational age of delivery in subgroups 
was: before 27 weeks and 6 day — 26 weeks and 0 days 
in PPROM group and 25 weeks 5 days in control group 
(p > 0.05), from 28 weeks and 0 days to 33 weeks and 6 days 
— 31 weeks and 4 days in both groups (p > 0.05) and from 
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34 weeks and 0 days to 37 weeks and 0 days — 35 weeks 
and 3 days in PPROM group and 35 weeks 4 days in control 
group (p < 0.05).
The median gestational age of PPROM in the study 
group was 33 weeks 5 days (from 21 weeks and 4 days 
to 36 weeks and 6 days). In details: in the group of pa-
tients who delivered before 27 weeks 6 days — 24 weeks 
6 days, from 28 weeks 0 days to 33 weeks 6 days — 30 weeks 
1 day, from 34 weeks 0 days to 37 weeks 0 days — 35 weeks 
2 days. The median time from PPROM to delivery was 1 day 
(0 to 71 days); 9 days in patients, who delivered before 
28 weeks of gestation; 11 days in patients who delivered 
from 28 weeks and 0 days to 33 weeks and 6 days and 1 day 
in patients who delivered after 33 weeks and 6 days. In the 
analyzed group 42 patients (33%) delivered on the day, 
when PPROM occurred, while 85 (66.9%) delivered later. 
Among 42 pregnant women who delivered on the day of 
PPROM, gestational age of 36 (85.7%) of them was greater 
than 33 weeks 6 days of gestation, when in 6 (14.3%) of them 
was between 28 weeks 0 days and 33 weeks 6 days. None 
of PPROM patients who delivered before 28 weeks of preg-
nancy delivered on the day when PPROM occurred. 
Positive culture of cervical swabs were noted in 62 pa-
tients with PPROM (49%) and in 51 patients in the control 
group (36%) (p > 0.05, p = 0.101); in 3 patients (27%), who 
delivered before 28 weeks of gestation in the PPROM group 
and in 5 patients (50%) in the control group (p > 0.05); in 
27 patients (56 %), who delivered from 28 weeks 0 days to 
33 weeks 6 days in the PPROM group and in 16 patients 
(36%) in the control group (p = 0.06); in the group of pa-
tients who delivered from 34 weeks 0 days to 37 weeks 
0 days — in 32 pregnant in the PPROM group (47%) and in 
30 patients (35%) in the control group (p < 0.05). Increased 
leukocytosis was noted at least once during latent period in 
65 women with PPROM (51.2%), in the control group leuko-
cytosis greater than 15000 was found in 43 patients (30.7%) 
(p < 0.001). In details, in the study and in the control group 
in 6 patients (54%) versus 3 patients (33%) who delivered 
before 28 weeks of pregnancy, in 30 patients (62%) versus 
18 patients (38%) who delivered from 28w0d to 33w6d and 
in 29 patients (43%) versus 22 patients (27%) who delivered 
later (p > 0.05; p < 0.05; p < 0.05; respectively) increased 
leukocytosis was noted. CRP above 5 was observed in 77 pa-
tients (68.7%) in the study group versus 29 patients (56.9%) 
in the control group (p < 0.001 and p > 0.05). CRP wasn’t 
evaluated in 15 patients (12%) from the study group and 
in 90 patients (63.8%) from the control group.
During latent time prophylactic antibiotics were used 
in 73 patients (57.5%) in the group of PPROM patients. Ad-
ditionally, antibiotics were administered if increased CRP, 
leukocytosis or positive microbiological swab was observed. 
To conclude, antibiotics were given to 99 patients in the 
PPROM group before delivery (78%), while in the control 
group 50 patients (35.5%) (p < 0.001).
Steroids were administered in 66 patients before 
34 weeks 6 days in the study group (52%), and in 49 pa-
tients in the control group (35%) (p < 0.05); in a group of 
women who delivered before 28w0d in 10 (90%) in the 
PPROM group and in 7 (70%) in the preterm delivery group; 
in a group of patients who delivered from 28w0d to 33w6d 
in 41 (85%) in the study group and in 27 (56%) in the con-
trol group. Patients who delivered after 33w6d received 
steroids in 22% (15 pregnant) in the PPROM group and in 
18% (15 pregnant) in the control group (p > 0.05, p < 0.05, 
p > 0.05; respectively).
In the study group 77 patients (61%) delivered vaginally 
— 73% (8 pregnant women) before 28w0d, 59% (28 preg-
nant) from 28w0d to 33w6d and 60% (41 pregnant women) 
from 34w0d to 37w0d. In the remaining 50 women (39%), 
cesarean sections were performed. In the control group, 
38 patients delivered vaginally (27%) — 30% (3 pregnant 
women) before 28w0d, 29% (13 pregnant women) from 
28w0d to 33w6d and 27% (22 pregnant women) from 
34w0d to 37w0d. Cesarean sections were performed in 
103 patients (73%). The cesarean section rate was higher in 
the control group (p < 0.001) and in the subgroups this trend 
was also observed (p = 0.05, p < 0.05, p < 0.05).
The cesarean section in the study group was performed 
most frequently due to fetal distress (28 women — 58.3%) or 
intrauterine infection (10 women — 20.8%), but also due to 
fetal malpresentation (9 women — 18.8%), placental abrup-
tion (2 women — 4.2%), preeclampsia (1 woman — 2.1%), 
threatening rupture of uterus (4 women — 8.3%) and ma-
ternal indications (8 women — 16.7%), fetal indications 
(1 woman — 2.1%). Indications for cesarean sections in the 
control group was mostly fetal distress (66 women — 64.7%). 
Other indications were: intrauterine infection (3 women 
— 2.9%), fetal malpresentation (8 women — 7.8%), placental 
abruption (6 women — 5.9%), preeclampsia (15 women 
— 14.7%), threatening rupture of uterus (4 women — 3.9%) 
and maternal indications (13 women — 12.7%), fetal indi-
cations (4 women — 3.9%). In three cases, indications for 
cesarean section were unknown. The group of extremely 
preterm infants consisted of 11 neonates (9%) in the PPROM 
group and 10 neonates (7%) in the preterm delivery group, 
moderate preterm infants — 48 (38%) in the PPROM group 
and 47 (33%) in the preterm delivery group, late preterm 
infants — 68 (53%) in the PPROM group and 84 (60%) in 
the control group (p > 0.05, p > 0.05, p < 0.05).
 The average birth weight was similar in the study and 
the control group (2117.9 g and 2245.0 g respectively, 
p > 0.05). In extremely preterm infants it was 938 g and 
832 g (p > 0.05), in moderate preterm infants 1717 g and 
1766 g (p > 0.05) and in late preterm infants 2589 g and 
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2667 g (p > 0.05) in the PPROM group and the control group 
respectively.
The rate of neonate survival to discharge was similar 
in both groups (93.7% and 94.1% respectively; p > 0.05). 
Rates of survival increased with increasing gestational age 
in both groups; in the PPROM group: 73% (< 28w0d), 94% 
(from 28w0d to 33w6d), 99% (from 34w0d to 37w0d) and 
in the control group: 60%, 94%, 97% respectively (p < 0.05, 
p > 0.05, p > 0.05).
Incidence of neonatal respiratory distress syndrome was 
similar in both groups (42.5% vs 45%; p > 0.05). In extremely 
preterm infants in 90% (10 neonates) and in 89% (8 neo-
nates) (p > 0.05), in moderate preterm infants in 35 (73%) 
and in 35 neonates (74%) (p > 0.05), in late preterm infants 
in 10 neonates (15%) and in 21 neonates (25%)  (p > 0.05) 
in the PPROM group and the control group respectively.
Assisted ventilation was used in 48 neonates (38%) in the 
study group and in 59 children (42%) in the control group 
(p > 0.05); in 10 neonates (90%) and in 8 neonates (80%) in ex-
tremely preterm infants (p > 0.05), in 32 neonates (66%) and 
in 34 neonates (74%) in moderate preterm infants (p > 0.05), 
in 6 neonates (9%) and in 17 neonates (20%) in late preterm 
infants (p = 0.059). Congenital infection was diagnosed more 
often in the group of neonates from PPROM pregnancies 
(45 neonates) than in neonates from the control group (29 ne-
onates); (36% and 21.2% respectively; p = 0.009). In detail, 
infection was present in 6 (55%) extremely preterm neonates 
in the PPROM group and in 3 (37%) in the control group 
(p > 0.05), in 25 (52%) moderate preterm neonates in the 
PPROM group and in 14 (31%) in the control group (p < 0.05) 
and in 13 (19%) late preterm neonates in study group and in 
11 (13%) in preterm delivery group (p > 0.05).  Differences 
were also noted regarding leukocytosis in neonate above 
15 000/dL (61.5% and 49.2% respectively), but it was not 
statistically significant (p = 0.059). In detail, high leukocytosis 
was found in extremely preterm in 66% (6 neonates) and 
37% (3 neonates) (p > 0.05), in moderate preterm infants 
in 56% (26 neonates) and in 40% (18 neonates) (p > 0.05) 
and in late preterm infants in 60% (40 neonates) and in 50% 
(41 neonates) (p > 0.05) in the PPROM group and the control 
group respectively.
Number of neonates with CRP above 5 was similar in 
both groups (22.3% and 24.4% respectively; p > 0.05). In 
extremely preterm infants CRP was above 5 in 33% (3 neo-
nates) versus 37% (3 neonates) (p > 0.05), in moderate pre-
term infants 38% (17 neonates) versus 35% (15 neonates) 
(p > 0.05) and in late preterm infants 12% (8 neonates) versus 
17%  (14 neonates) (p > 0.05) in the PPROM group and the 
control group respectively.
Antibiotic therapy was administered in 88 (69%) of 
neonates from the study group versus 80 (61%) neonates 
from the control group (p = 0.04). In extremely preterm 
infants antibiotics were given to 10 neonates (90%) and in 
9 neonates (90%) (p > 0.05), in moderate preterm infants 
in 47 neonates (98%) and in 44 neonates (94%) (p > 0.05) 
and in late preterm infants in 31 neonates (45%) and in 
28 neonates (34%) (p > 0.05) in the PPROM group and the 
control group respectively.
Median hospital stay of the neonates in the study group 
was 11 days (0 to 79 days) and in the control group — 8 days 
(0 to 82 days), and the difference wasn’t significant (p > 0.05). 
In extremely preterm infants it was 67 and 54 days (p > 0.05), 
in moderate preterm infants 25 and 30 days (p > 0.05) and 
in late preterm infants 8 and 9 days (p > 0.05) in the PPROM 
group and control group respectively.
DISCUSSION
According to Romero’s definition preterm labor results 
from “pathological activation” of one or more components 
of “common pathway of parturition”. Uterine myometrial 
contractility, cervical ripening and membranes rupture, if 
activated synchronously are said to be the most important 
factors leading to preterm delivery. Asynchronous activation 
of one of these components results in cervical insufficiency, 
preterm uterine contractions or preterm premature rupture 
of membranes [11, 12]. So far there are many dimensions 
identified as responsible or connected with mentioned 
above clinical situations [12]. Prostaglandins and matrix- 
-degrading enzymes (mediators of infection) are considered 
to be crucial factors in collagen degradation and weaken-
ing of membranes, which leads to its rupture [13]. Clinical 
studies have confirmed infectious theory — bacteria’s have 
the ability to cross even intact membranes and positive am-
niotic fluid cultures are identified in 12.8% of patients with 
preterm birth and 32% with preterm premature rupture of 
membranes according to Romero’s researches [14]. Caroll 
S.G. et al. [15] showed that positive culture of swabs from 
the vagina predicts 53% of intraamniotic infections. In our 
study we haven’t examined amniotic fluid for presence of 
microbial invasion, but we also observed positive culture 
of cervical swab significantly more frequent in group of 
patients with rupture of membranes than in patients with 
preterm birth. Similarly, increased leukocytosis and CRP 
were noted more often in groups of pregnant women with 
PPROM than in groups of patients with preterm birth. CRP 
isn’t routinely ordered in case of patients with risk of pre-
term delivery, that’s why increased value of this marker was 
observed only in 13% of patients among the patients in this 
group. According to literature neither CRP nor leukocytosis 
are considered to be highly specific in detecting intrauterine 
infection and are not even recommended in some countries 
to be assessed. The estimated sensitivity rate of leukocy-
tosis in detecting chorioamnionitis is 29–47% [16], when 
specificity of CRP is 38–55% [17]. Antibiotics were applied 
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in groups of PPROM patients more often than in control 
groups. Antibiotics weren’t offered routinely to everyone. 
Due to hospital regulation, antibiotics were offered prophy-
lactically or in case of increased inflammatory indicators or 
symptoms of infection.
Nowadays, according to Polish Society of Gynecologists 
and Obstetricians the most optimal approach to manage-
ment of PPROM patients is expectant management with 
antibiotics therapy to prolong latency of pregnancy. After 
34 weeks of pregnancy induction of delivery with oxytocin 
is indicated only if intrauterine infection is suspected. Re-
gardless of clinical management birth in 7 days follow-
ing rupture of membranes occurs in 50% patients [3]. The 
median length of latency from PPROM to delivery in the 
examined group was 1 day (from 0 to 71 days). Comparing 
to other publications, median latency time in the PPROM 
group was short because in the evaluated group nearly half 
consisted of patients after 34 weeks of gestation, where due 
to hospital regulation and ACOG recommendations active 
management was recommended. In patients with PPROM 
before 28 weeks of gestation median latency time was 9 days 
and 11 days if delivery took place between 28 + 0 to 33 + 6, 
similar results were presented by A. Peaceman. In a group of 
1377 patient’s median latency time between 24–28 weeks 
was approximately 9 days, and between 30–31 weeks was 
6 days [18]. 
The difference in the frequency of cesarean section 
was observed in the research. This operative procedure 
was more often performed in group of patients with intact 
membranes than in PPROM group. The main indication for 
cesarean section in both groups was fetal distress, while in 
the group of PPROM patients could have been related to ac-
tive management (induction of delivery) in case of patients 
after 34 weeks of gestation. Threatening intrauterine infec-
tion was the second main indication for cesarean section in 
the PPROM group, what is consistent with published data.
Congenital infection was more often detected in all sub-
groups of neonates from the study group than the control 
group, what is consistent with fact of higher incidence of 
increased parameters of inflammation and positive cervical 
swabs in pregnant with PPROM. As a consequence of this, 
antibiotics were also more often administered in the study 
group. Comparable results were published by Moratti [19]. 
According to data published by Bengtson and Dale [20, 21] 
respiratory distress syndrome incidence in neonates from 
pregnancies complicated by PPROM is evaluated to be 
10–40%. In general, in our study we noticed high ratio of 
respiratory distress, comparable in both groups of neo-
nates (42.5% and 45%). In case of extremely and moderate 
preterm neonates, it was a result of early gestational age at 
delivery and impossibility of steroids administration. In the 
group of neonates delivered after 34 weeks of gestation, res-
piratory distress syndrome was more often observed in the 
control group, which is probably connected with the high 
percentage of cesarean section performed in this group. 
Considering neonatal survival rate, we haven’t found 
significant difference between both groups of patients. Ne-
onatal death mostly occurred in cases of neonates born 
before 26 weeks of gestation with low birth weight. Glass 
estimates that extremely premature infants with extremely 
low birth weight have 30–50% risk of mortality and 20–50% 
risk of morbidity in survivors [22]. Probably, if patients with 
PPROM (especially after 28th week of pregnancy) are appro-
priately covered with antibiotics, which increases the latent 
time of pregnancy and offers the possibility of steroids and 
magnesium sulfate administration, the presence of PPROM 
doesn’t influence the rate of mortality in neonates.
CONCLUSIONS
Our research appears to be consistent with theory of 
inflammatory etiology of PPROM. Optimal management 
of infection in PPROM patients seems to be the most impor-
tant in efforts to prolong latency of pregnancy and decrease 
mortality and morbidity in neonates.
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